Conmed Q4 Earnings Assessment

Comments
Loading...

Conmed CNMD announced its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.

Here's a breakdown of the earnings report.

Earnings

Conmed beat estimated earnings by 12.0%, reporting an EPS of $1.34 versus an estimate of $1.2.

Revenue was up $18.90 million from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.06, leading to a 5.0% increase share price change the next day.

Here's a look at Conmed's past performance:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate 0.99 0.91 0.74 1.11
EPS Actual 1.05 0.98 0.79 1.06
Revenue Estimate 318.13M 332.32M 306.78M 332.20M
Revenue Actual 316.70M 332.10M 312.27M 327.05M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Conmed management provided guidance for FY 2025, expecting earnings between $4.25 and $4.4 per share.

To track all earnings releases for Conmed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNMD Logo
CNMDConmed Corp
$62.74-%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum17.31
Growth15.67
Quality64.48
Value38.10
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: